REVIEWER
Hans Garmo School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK REVIEW RETURNED 14-Aug-2018
GENERAL COMMENTS
2. Is the abstract accurate, balanced and complete?
In the abstract it is stated that the authors intend to create a "a new nomogram". When reading the full text, it becomes clear that they have created "three new nomograms". To put it more precisely they have shown that by adding age (continuous) and the variable "ST depression or tall T wave" (Yeas/No) the three Scoring systems: WFNS, HH, and Fisher grade the AUC increases. I think that rather than claiming that "a new nomogram" is created the abstract should reveal that that by adding age (continuous) and the variable "ST depression or tall T wave" (Yes/No) to three Scoring systems: WFNS, HH, and Fisher grade the ability to predict Poor outcome as defined in the paper.
4. Are the methods described sufficiently to allow the study to be repeated? Most or the methods are sufficiently described. What lacks is the information that the scoring systems are all considered continuous. As the scores has 4 or 5 levels (depending on scoring system) they could equally well have been considered as factors (with 4 or 5 levels). I would prefer that the sentence "Each scoring system was entered individually into the multivariate logistic regression analysis with clinical variables, CT findings, and ECG abnormalities" should be changed so that it becomes clear that the scoring systems were entered individually as continuous variables into the model.
7. If statistics are used are they appropriate and described fully?
The authors use t-tests to compare the three scoring systems between Good outcome and Poor outcome individuals. T-test assume an underlying normal distribution. Factors wit 4-5 levels cannot be normally distributed. Use either fishers exact test also for the scores or use a Wilcoxon test. (My guess is that the pvalues will still be <0.001 but at least a correct test will be used). The remaining statistics is OK as far as I can see.
Are they presented clearly?
Since it took me a long time to realise that the paper was about "could the combination of age and ST depression or tall T wave improve the predictive capacity of the scores WFNS, HH, and Fisher grade?" I guess that some clarifying details are missing. Maybe the title should be changed so that becomes clear that the paper is about adding information on age and ST depression/tall T wave to already existing scores and by that improving the predictive value of the scores.
outcomes) -please could authors amend the terminology from multivariate to multivariable 2. In the abstract there is no methods sections and seems to be embedded in the results section. These need the be separate 3. There seem to be three models which are developed and validated, these need to be more explicitly stated 4. P7 lines 33-36 = results, these also alludes that the developed models are compared to existing ones but no description of existing models is given. This needs to be clarified. 5. Figures are hard to see and interpret -need to be bigger and reader friendly, accounting for colour blindness 6. Authors mention blinding on ECG predictor, was any blinding used for outcome assessment? 7. Please could authors change notation of mean±SD to mean (SD) 8. There is no information about the sample size 9. There is no information on missing data and how this was handled 10. Figures present apparent and bias corrected calibration plots alluding that bootstrapping methods were used. However, these are not described in the methods, and it is also not conducted for discrimination. Clarity and consistency is needed here 11. 'Nomograms for the predictions of prognosis' (page 10, lines 39-56) should be in the methods 12. Description of external validation sample is also needed in the methods.
13. Full prediction model should be presented, including coefficients, and the scoring system. 14. The authors may find the TRIPOD statement (plus the explanation and elaboration paper) a useful tool to aid reporting of the study and address my comments.
VERSION 1 -AUTHOR RESPONSE
Responses to Reviewer #1: Eddy Lang From a methodologic perspective I appreciate the addition of the TRIPOD reporting standard for predictive models as an appendix for reviewers. Of particular concern in relation to this paper is whether predictor and outcome variables were defined in a blinded and independent manner. Response: Thank you for taking the time to review my article and for this thoughtful comment. We collected ECG findings and outcome variables in a blinded and independent manner. We have added the following sentence to the Methods section to clarify this. "One investigator (J. Y. H.) retrospectively collected the data through a review of the medical records. We collected demographic data, vital signs on admission, and past medical history, including a history of hypertension, diabetes mellitus, and cardiovascular and cerebrovascular diseases. The Glasgow Coma Scale (GCS), HH, and WFNS scores were obtained from assessing the neurological abnormality and the level of consciousness. Patient outcome was assessed using the Glasgow Outcome Scale (GOS) and blinded to the ECG findings. The amount of blood, the location and size of cerebral aneurysm, and the presence or absence of intraventricular haemorrhage (IVH) and intracerebral haemorrhage (ICH) were determined based on CT scans reported by board-certified radiologist. ECG findings were assessed by another emergency physician blinded to patient prognosis using the Marquette Universal System of Electrocardiography."
Overall, I think this report is interesting and does a good job raising the issue of EKG findings as an adjunct to existing systems. The authors emphasize the importance and relevance to the ED setting as the hyper-adrenergic changes that are often acute may best manifest there. I am uncertain however, whether in practical terms, this EKG-based refinement of existing SAH prognostic scores would really add very much to existing emergency medicine practice where imaging and clinical information are the drivers of prognostic assessment. The practical utility of using a nomogram to inform family and colleagues about a given patient's prognosis seems unrealistic as well.
Response: Thank you for your comment. Indeed, it is important that this new prognostic modality is practical in real-life situations. For this, this new tool has to have a higher prognostic performance than that of existing disease severity scores and should be easy to use. The AUC values of our new nomograms were significantly higher than those of the WFNS scale, HH system, and Fisher scale itself. Its calibration plots also presented an excellent agreement between the predicted and observed probabilities of the prognosis. A nomogram is a user-friendly graphical representation of a statistical predictive model that generates a numerical probability of a clinical event. Moreover, our nomograms used only three prognostic factors, namely, widely used conventional scoring systems, age, and ECG changes, which can be easily obtained in the emergency environment. Therefore, our new nomograms can be potentially used in real-life situations. Of course, its application in the field should be analysed, and further prospective studies are needed. We have added the following sentence to the Discussion section (in the paragraph on the study limitations). "We need to assess the applicability of our new nomograms in future prospective studies and to validate them in a multi-centre study."
Responses to Reviewer #2: Athanasios K. Petridis The paper is well written and the message is clear. It remains to see how applicable the nomograms will be in future prospective studies. Response: Thank you for this helpful comment. We have added the following sentence to the Discussion section (in the paragraph on the study limitations). "We need to assess the applicability of our new nomograms in future prospective studies and to validate them in a multi-centre study."
The self fulfilling prophecy does not apply for a retrospective study. Response: We agree with your point. Per your recommendation, we have deleted the sentences on the self-fulfilling prophecy from the Strengths and limitations section of the article summary and from the Discussion section (in the paragraph on the study limitations).
Responses to Reviewer #3: Hans Garmo 2. Is the abstract accurate, balanced and complete?
In the abstract it is stated that the authors intend to create a "a new nomogram". When reading the full text, it becomes clear that they have created "three new nomograms". To put it more precisely they have shown that by adding age (continuous) and the variable "ST depression or tall T wave" (Yeas/No) the three Scoring systems: WFNS, HH, and Fisher grade the AUC increases. I think that rather than claiming that "a new nomogram" is created the abstract should reveal that that by adding age (continuous) and the variable "ST depression or tall T wave" (Yes/No) to three Scoring systems: WFNS, HH, and Fisher grade the ability to predict Poor outcome as defined in the paper. Response: Thank you for your kind comments and for pointing out this. We have reviewed our abstract and noticed the need to write it more clearly. We have revised the Abstract according to your suggestion:
"To develop new nomograms by adding electrocardiogram changes (ST depression or tall T wave) and age to three conventional scoring systems, namely, World Federation of Neurosurgical Societies (WFNS) scale, Hunt and Hess (HH) system, and Fisher scale, that can predict prognosis in patients with subarachnoid haemorrhage (SAH) using our preliminary research results and to perform external validation of the three new nomograms." We have also revised the Introduction and Methods sections accordingly.
4. Are the methods described sufficiently to allow the study to be repeated? Most or the methods are sufficiently described. What lacks is the information that the scoring systems are all considered continuous. As the scores has 4 or 5 levels (depending on scoring system) they could equally well have been considered as factors (with 4 or 5 levels). I would prefer that the sentence "Each scoring system was entered individually into the multivariate logistic regression analysis with clinical variables, CT findings, and ECG abnormalities" should be changed so that it becomes clear that the scoring systems were entered individually as continuous variables into the model. Response: Thank you for pointing this out. As advised, we added the following sentence in the Tables 1 and 2 as follows: "Categorical variables were described as frequencies (%). Parametric data are presented as mean (SD) and non-parametric data are presented as the median and interquartile range (IQR). We used the independent t-test for comparison of two groups distributed normally, whereas the Mann-Whitney U test was used for comparison of two groups that were not distributed normally. Fisher's exact test was used for categorical variables." Table 1 Good outcome Poor outcome Total p values (n=111) (n=91) (n=202) Scoring systems WFNS scale 1 (1~1) 4 (2~5) 2 (1~4) <0.001 HH system 2 (2~2) 4 (3~5) 3 (2~4) <0.001 Fisher grade 3 (3~3) 4 (3~4) 3 (3~4) <0.001 Table 2 Good outcome Poor outcome Total p-value (n=77) (n=64) (n=141) Scoring systems WFNS scale 1 (1~1) 3 (1~4) 1 (1~4) <0.001 HH system 2 (2~2) 3 (2~4) 2 (1~4) <0.001 Fisher grade 3 (3~3) 4 (3~4) 3 (3~4) <0.001 10. Are they presented clearly? Since it took me a long time to realise that the paper was about "could the combination of age and ST depression or tall T wave improve the predictive capacity of the scores WFNS, HH, and Fisher grade?" I guess that some clarifying details are missing. Maybe the title should be changed so that becomes clear that the paper is about adding information on age and ST depression/tall T wave to already existing scores and by that improving the predictive value of the scores. Response: Thank you for this thoughtful comment. It appears that our title was unclear. As per your recommendation, we have changed the Title as follows: "Development and external validation of new nomograms by adding electrocardiogram changes (ST depression or tall T wave) and age to conventional scoring systems to improve the predictive capacity in patients with subarachnoid haemorrhage."
Responses to Reviewer #4: Paula Dhiman 1. What authors report are multivariable models (model with multiple variables ), not multivariate (assessment of multiple outcomes) -please could authors amend the terminology from multivariate to multivariable Response: As suggested, we changed all instances of "multivariate logistic regression" to "multivariable logistic regression."
2. In the abstract there is no methods sections and seems to be embedded in the results section. These need the be separate Response: We have rechecked the submission guideline of BMJ Open. We confirm that the submission guidelines for the Abstract do not mention the need for a methods section per say; however, per the guidelines the methods need to be discussed under design, setting, participants, primary and secondary outcomes. We have revised our abstract according to this guideline.
3. There seem to be three models which are developed and validated, these need to be more explicitly stated 12. Description of external validation sample is also needed in the methods. Response: We have reviewed our manuscript and noticed the need to write clear expressions. The following sentence was added to the Abstract: "To develop new nomograms by adding electrocardiogram changes (ST depression or tall T wave) and age to three conventional scoring systems, namely, World Federation of Neurosurgical Societies (WFNS) scale, Hunt and Hess (HH) system, and Fisher scale, that can predict prognosis in patients with subarachnoid haemorrhage (SAH) using our preliminary research results and to perform external validation of the three new nomograms."
In line with the reviewer's comment, we have added a detailed description of the external validation sample to the Methods and Results section and revised Figure 1 as follows:
"We performed a retrospective, observational study to develop new nomograms that can predict prognosis of patients with SAH and to perform external validation of the new nomograms. This study was conducted on two independent cohorts of patients with SAH from two hospitals. We enrolled patients with SAH diagnosed by brain computed tomography (CT) scans or xanthochromia of cerebrospinal fluid in the emergency department (ED) of Severance Hospital between January 2009 and March 2015 as primary cohort. Exclusion criteria were as follows: 1) age under 19 years; 2) administration of a cardiovascular drug, such as calcium-channel blockers, with no baseline ECG; 3) cardiac arrest on arrival; and 4) traumatic SAH. Additionally, patients were excluded if they were referred from other hospitals because initial ECG could not be obtained and patients were often treated with medication affecting the cardiovascular system. Patients referred to other hospitals from the ED were also excluded as their prognosis could not be evaluated. For model external validation, 141 patients with SAH were enrolled in another ED of Gangnam Severance Hospital between January 2011 and December 2014 according to the inclusion and exclusion criteria. We collected sufficient data to score all variables in the established nomogram." "The new nomograms were externally validated using the independent dataset (Fig. 1 ) listed in Table  2 ." Figure 1 . Flow diagram of the study subjects.
4. P7 lines 33-36 = results, these also alludes that the developed models are compared to existing ones but no description of existing models is given. This needs to be clarified. 11. 'Nomograms for the predictions of prognosis' (page 10, lines 39-56) should be in the methods. Response: Thank you for this valuable advice. In line with your comment, we have revised the Methods sections of the manuscript as follows: "From the preliminary study, age, ECG changes (ST depression or tall T wave) and three conventional scoring systems such as WFNS scale, HH system, and Fisher scale were selected to predict prognosis in patients with SAH on the basis of the results of multivariable logistic regression using backward Wald selection. As ST depression and tall T wave formation do not occur simultaneously, they were considered one variable. The scoring systems were entered individually as continuous variables into the model with clinical variables, CT findings, and ECG abnormalities. In this study, we developed three simplified nomograms including age, ECG changes, and each scoring system and compared the predictive performance of new nomograms with those of the WFNS scale, HH system, and Fisher scale" Further, we moved the following sentences to the footnote of 6. Authors mention blinding on ECG predictor, was any blinding used for outcome assessment? Response: Thank you for this question. In this study, the ECG findings and outcome variables were collected in a blinded and independent manner. We have added the following sentence to the Methods section to clarify this "One investigator (J. Y. H.) retrospectively collected the data through a review of the medical records. We collected demographic data, vital signs on admission, and past medical history, including a history of hypertension, diabetes mellitus, and cardiovascular and cerebrovascular diseases. The Glasgow Coma Scale (GCS), HH, and WFNS scores were obtained from assessing the neurological abnormality and the level of consciousness. Patient outcome was assessed using the Glasgow Outcome Scale (GOS) and blinded to the ECG findings. The amount of blood, the location and size of cerebral aneurysm, and the presence or absence of intraventricular haemorrhage (IVH) and intracerebral haemorrhage (ICH) were determined based on CT scans reported by board-certified radiologist. ECG findings were assessed by another emergency physician blinded to patient prognosis using the Marquette Universal System of Electrocardiography." 7. Please could authors change notation of mean±SD to mean (SD) Response: Per your recommendation, we have changed all notation of mean±SD to mean(SD).
8. There is no information about the sample size Response: We have added the sample size calculation to the Methods section accordingly: "The sample size was calculated on the basis of the area under the receiver operating characteristic curve (AUC) of the nomogram. A difference of 0.1 between the conventional scoring system with an AUC of 0.78 and new nomogram with an AUC of 0.88 was selected as the minimum clinically significant value. We assumed that the allocation ratio of good and poor outcome group was 4.5 to 5.5. The correlation between the two predictive models was assumed to be 0.5. We estimated that a sample size of 183 patients would be sufficient to evaluate the primary outcome at a significance level of 0.05 (two-sided) with 80% power. The validation cohort was 70% of the primary cohort."
9. There is no information on missing data and how this was handled Response: Thank you for this helpful comment. We excluded patients referred from other hospitals because the initial ECG could not be obtained. We also excluded the patients without initial ECG. However, there were no missing data because all variables used were collected in usual practice.
10. Figures present apparent and bias corrected calibration plots alluding that bootstrapping methods were used. However, these are not described in the methods, and it is also not conducted for discrimination. Clarity and consistency is needed here Response: Thank you for this valuable advice. In line with your comment, we revised the manuscript in the Methods sections as follows: "The performance of the nomograms in predicting outcomes was validated with respect to discrimination and calibration. Nomogram predictive accuracy (discrimination) is measured via a concordance index (c-index), analogous to the area under the receiver operating characteristic curve (AUC), which quantifies the level of concordance between predicted probabilities and the actual chance of the event of interest occurring. A value of 0.5 indicates no predictive discrimination, and a value of 1.0 indicates perfect separation of patients with different outcomes. The Delong method was used to compare the C-indexes of each model. Calibration of the nomogram determines how far the predicted probabilities are from the observed outcome frequencies using graphic representations (calibration curve). A plot along the 45-degree line would indicate a perfect calibration model in which the predicted probabilities are identical to the actual outcomes. The calibration curves are presented as apparent and bias-corrected calibration plots using the bootstrapping methods with 200 resamples."
We have also added ROC curves of the primary cohort in Figure 3. 13. Full prediction model should be presented, including coefficients, and the scoring system. Response: Thank you for this valuable advice. To reflect your comment, we have added the predicted probability of each nomogram to the footnote of 14. The authors may find the TRIPOD statement (plus the explanation and elaboration paper) a useful tool to aid reporting of the study and address my comments. Response: Thank you for this comment. We used the TRIPOD statement to revise our manuscript.
VERSION 2 -REVIEW

REVIEWER
Eddy Lang University of Calgary, Canada REVIEW RETURNED 01-Nov-2018
GENERAL COMMENTS
The authors of this work present a refinement of established subarachnoid hemorrhage prognostication instruments largely based on neurologic status and / or imaging findings related to the burden of bleeding. By incorporating age and EKG findings they validate an updated model in a moderately sized cohort of patients. The paper is well-written and the science is robust. The investigators make a good case for how these changes lead to further refinement of the rule what is less clear is to whether these changes would meet the threshold for utility and incorporation into clinical practice. They've done a solid job addressing previous reviewers' comments.
REVIEWER
Paula Dhiman
University of Oxford, UK REVIEW RETURNED 06-Nov-2018
GENERAL COMMENTS
The authors have significantly improved their paper in response to reviewer's comments, and using the TRIPOD checklist. I have a few minor comments for clarification and further improvement for the paper, and one major comment around the justification for the development of the 3 models [comment 3].
[1] Page 7, line 11-12: It is unclear how patient outcome was blinded to the ECG findings?
[2] Page 7, line 56: It is unclear which cohort the authors are referring to when saying 'validation cohort was 70% of the primary cohort' -is this for the internal validation. Further, as it reads, this suggests the data was split 30:70 which I don't think is the case as they later mention bootstrapping. I assume 70% of the development cohort was used for the internal validation and bootstrapping technique?
[3] I have 2 linked comments around the development of the models:
[3a] Authors develop 3 models, however not much justification is given around why, other than the 3 scoring systems are used 'widely and globally'. Given that all 3 models have a common primary outcome, I wonder why all 3 models are needed? This may be stemming from my clinical ignorance in the area, but would having 1 model not be enough? Otherwise we are in danger of having too many models to use for a single outcome and then choosing which is best.
[3b] This also somewhat confuses the message of the paper, is the authors main aim to develop new models, or are they updating the models by adding ECG, thus exploring the added value of ECG? I think this need clarification. This is something which could be addressed in the introduction and also the discussion (may be suggesting further research to compare and identify the single best model to use?).
[4] The authors have clarified the missing data in the study, but this is only presented in the TRIPOD checklist -this should be stated in the paper too. I don't think what is stated in Figure 1 is enough to cover this alone.
[5] Figure 2 is still quite difficult to see.
[6] In tables 1 and 2, could authors clarify when presenting mean(SD) and median(IQR)
I think addressing these points will further improve the paper for publication.
VERSION 2 -AUTHOR RESPONSE
Responses to Reviewer #4: Paula Dhiman 1. Page 7, line 11-12: It is unclear how patient outcome was blinded to the ECG findings?
3. I have 2 linked comments around the development of the models:
3a. Authors develop 3 models, however not much justification is given around why, other than the 3 scoring systems are used 'widely and globally'. Given that all 3 models have a common primary outcome, I wonder why all 3 models are needed? This may be stemming from my clinical ignorance in the area, but would having 1 model not be enough? Otherwise we are in danger of having too many models to use for a single outcome and then choosing which is best.
Response: In this study, we used three scoring systems which have been widely used globally. These three scoring systems were used to classify the severity of a subarachnoid haemorrhage based on different criteria. The Hunt and Hess (HH) system was based on the patient's clinical condition, the Fisher scale was based on the amount of blood shown on initial CT scans, and the World Federation of Neurosurgical Societies (WFNS) scale was based on GCS combined with the presence or absence of focal deficits. In clinical situation, clinicians use all these scoring systems to discuss the patient's condition. For example, when I told the other physician that the patient was a HH grade 1 and Fisher grade 2, he could understand that the patient has asymptomatic or mild headache and the CT finding of the patient was minimal SAH (<1 mm thickness). For this reason, three conventional scoring systems were incorporated in our prognostic models. Because there was no significant difference in the predictive accuracy of the three newly established models, clinicians could choose one of the new models according to the clinician's preference.
3b.This also somewhat confuses the message of the paper, is the authors main aim to develop new models, or are they updating the models by adding ECG, thus exploring the added value of ECG? I think this need clarification. This is something which could be addressed in the introduction and also the discussion (may be suggesting further research to compare and identify the single best model to use?).
Response: As we described in the Introduction section, the above three systems do not include clinically important factors, such as comorbidity, age, and vital signs on admission, and differences between the grades for each system are ambiguous. Although electrocardiogram (ECG) abnormalities have also been studied as a prognostic factor of SAH patients, the existing system for predicting the prognosis of SAH patients does also not include ECG changes as a prognostic variable. Therefore, we conducted preliminary research to investigate the association between the abovementioned prognostic factors such as ECG changes, clinically important factors, three conventional scoring systems, and prognosis of SAH patients. In this study, we developed new nomograms including ECG changes that can predict prognosis of SAH patients and performed external validation of the new nomograms. Of course, we need to assess the applicability of our new nomograms in future prospective studies and validate them in a multi-centre study as we described in the Limitation section.
4. The authors have clarified the missing data in the study, but this is only presented in the TRIPOD checklist -this should be stated in the paper too. I don't think what is stated in Figure 1 is enough to cover this alone.
Response: We excluded patients referred from other hospitals because the initial ECG could not be obtained. We also excluded patients without initial ECG. However, there were no missing data because all variables used were collected in usual practice. As per your recommendation, we have added the following sentence to the Methods section:
